(Sharecast News) - Travis Perkins: Citigroup upgrades to buy with a target price of 1,900p.
Hochschild Mining: Berenberg reiterates hold with a target price of 190p.
Morgan Sindall: Liberum reiterates hold with a target price of 1,850p.
Spectris: Liberum reiterates hold with a target price of 2,400p.
Rathbone Brothers: Liberum reiterates hold with a target price of 2,100p.
Mondi: Deutsche Bank reiterates buy with a target price of 1,950p.
Meggitt: Credit Suisse reiterates underperform with a target price of 520p.
AstraZeneca: Barclays reiterates overweight with a target price of 8,500p.
GlaxoSmithKline: Barclays reiterates underweight with a target price of 1,550p.
Hikma Pharmaceuticals: Barclays reiterates equal weight with a target price of 1,900p.
Hochschild (HOC)
Astrazeneca (AZN)
Hikma Pharmaceuticals (HIK)
Morgan Sindall Group (MGNS)
Rathbone (RAT)
Spectris (SXS)
Travis Perkins (TPK)
Glaxosmithkline (GSK)
Mondi (MNDI)24 Apr 2024 10:12
Hochschild Mining hails surge in quarterly gold production
(Alliance News) - Hochschild Mining PLC on Wednesday reported a surge in its gold output for the three months to March 31, and said it is on track to ...